BloodCell BiologyPeer-reviewed journal article
MLL3 and MLL4 sustain hematopoietic stem cell multipotency by opposing a B-cell default state
Helen C. WangiD, Ran CheniD, Wei Yang, Rohini MuthukumariD, Tingting Hu, Riddhi M. PateliD, Emily B. Casey, Elisabeth Denby, Run ZhangiD, Guojia XieiD, Kai GeiD, Grant Anthony ChalleniD, Jeffrey J. BednarskiiD, Jeffrey A. MageeiD
Abstract
Hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) are sustained by networks of transcription factors and epigenetic regulators that prime lineage-specific programs yet maintain multipotency. Two epigenetic regulators, MLL3 and MLL4, play important but opposing roles in maintaining this balance. MLL3 promotes HSC differentiation, whereas MLL4 opposes differentiation. These opposing functions are essential for both normal homeostasis and leukemia suppression, yet it is not clear how MLL3 and MLL4 regulate HSC and MPP gene expression to control HSC/MPP fate decisions. To resolve these mechanisms, we performed an extensive series of single cell genomic studies after conditionally deleting Mll3, Mll4 or both genes together. Mll3 deletion had only limited effects on HSC/MPP enhancer networks at steady state, whereas Mll4 deletion led to precocious activation of myeloid enhancers. Surprisingly, compound Mll3/4 deletion eliminated all myeloid, erythroid and megakaryocytic potential within the hematopoietic hierarchy and caused all progenitors to rapidly default to a B-cell-like identity. These changes were accompanied by widespread inactivation of HSC/MPP enhancers and superenhancers, and ectopic activation of B-cell superenhancers. Disabling MLL3/4 histone methyltransferase activity did not recapitulate the pervasive changes in cell identity that were observed when MLL3 and MLL4 were fully inactivated, indicating that MLL3 and MLL4 activate HSC/MPP enhancers independently from their enzymatic activities. Our findings show that HSC/MPP multipotency requires sustained tension between MLL3/4-dependent enhancers that maintain myeloid, erythroid and megakaryocyte potential, and MLL3/4-independent enhancers that prime B-cell identity. MLL3 and MLL4 therefore serve as critical linchpins of multilineage hematopoiesis. KEY POINTSO_LIMLL3 and MLL4 act redundantly in HSCs to sustain transcription factor and enhancer networks that support multipotency C_LIO_LISimultaneous loss of MLL3 and MLL4 drives hematopoietic progenitors into a uniform B-cell-like default state C_LI
- organism: mouse
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 30th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MLL3/4 methyltransferases regulate the differentiation of pluripotent stem cells through coordinating glycolysis and mitochondrial respiration
Suza Mohammad Nur, Yunbo Jia, … Kaixiang Cao·bioRxiv·Apr 14, 2026
- Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during ESC differentiation
Ryan M. Boileau, Kevin X. Chen, Robert H. Blelloch·bioRxiv·Oct 24, 2022
- MLL3/MLL4 Histone Methyltranferase Activity Dependent Chromatin Organization at Enhancers during Embryonic Stem Cell Differentiation
- Loss of Ing4 enhances hematopoietic regeneration in multipotent progenitor cells
Georgina A. Anderson, Marco Hernandex, … Katie L. Kathrein·PLoS ONEPeer-reviewed·Feb 14, 2025
- MLL3/MLL4 methyltransferase activities control early embryonic development and embryonic stem cell differentiation in a lineage-selective manner
Guojia Xie, Ji‐Eun Lee, … Kai Ge·Nature GeneticsPeer-reviewed·Apr 1, 2023
- MLL1 is required for maintenance of intestinal stem cells and the expression of the cell adhesion molecule JAML
Neha Goveas, Claudia Waskow, … Andrea Kranz·bioRxiv·Nov 19, 2020